The National Hemophilia Foundation’s (NHF’s) Medical and Scientific Advisory Council (MASAC) met April 17–18 in Chicago and issued four recommendations for the bleeding disorders community. On June 9, the committee issued a fifth recommendation for a meeting of the US Department of Health and Human Services’ Advisory Committee on Blood Safety and Availability regarding potential changes to its blood donor deferral policy.
[Steps for Living: Blood Safety and Universal Data Collection]
MASAC comprises hematologists, other doctors, researchers and other experts on bleeding disorders. The recommendations are intended to set standards of care for the treatment of hemophilia and von Willebrand disease, and to set guidelines for blood safety.
Read the recommendations:
- MASAC Document #194: “MASAC Recommendations Regarding Radionuclide Synovectomy”
- MASAC Document #195: “MASAC Recommendations Concerning Products Licensed for the Treatment of Hemophilia and Other Bleeding Disorders” (Revised April 2010)
- MASAC Document #196: “MASAC Recommendations Regarding the Treatment of von Willebrand Disease”
- MASAC Document #197: “MASAC Recommendations Regarding Girls and Women with Inherited Bleeding Disorders”
- MASAC Document #199: “MASAC Resolution on Blood Donor Deferral Policy”